Skip to main content
Clinical Trials/DRKS00007821
DRKS00007821
Recruiting
Phase 4

Treatment of periimplant mucositis with PerioChip®.A randomized controlled clinical trial.

Zentrum für ZahnmedizinKlinik für Präventivzahnmedizin, Parodontologie und Kariologie0 sites40 target enrollmentJuly 23, 2015

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
mucositis
Sponsor
Zentrum für ZahnmedizinKlinik für Präventivzahnmedizin, Parodontologie und Kariologie
Enrollment
40
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 23, 2015
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Zentrum für ZahnmedizinKlinik für Präventivzahnmedizin, Parodontologie und Kariologie

Eligibility Criteria

Inclusion Criteria

  • Informed Consent as documented by signature
  • Systemically healthy subjects
  • At least one dental implant with mucositis in terms of a probing pocket depth less than 5 and bleeding on probing and no obvious bone loss (\< 2mm).
  • Ability to read and understand the patient inform

Exclusion Criteria

  • Patients with untreated periodontitis
  • Pregnant or nursing women
  • Patients with antibiotic therapy within the last 6 months
  • Patients with periimplantitis therapy within the last 3 months
  • Subjects with an allergy to or chlorhexidine
  • Anti\-coagulated patients
  • Periimplantitis: probing pocket depth more than 5 mm and obvious bone loss (\> 2mm)
  • Intake of medical products containing Nystatin

Outcomes

Primary Outcomes

Not specified

Similar Trials